Literature DB >> 18446497

Physicochemical properties and dissolution studies of dexamethasone acetate-beta-cyclodextrin inclusion complexes produced by different methods.

Mayara M Doile1, Keila A Fortunato, Iára C Schmücker, Sacha K Schucko, Marcos A S Silva, Patrik O Rodrigues.   

Abstract

Inclusion complexes between dexamethasone acetate (DMA), a poorly water soluble drug, and beta-cyclodextrin (betaCD) were obtained to improve the solubility and dissolution rate of this drug. Phase-solubility profile indicated that the solubility of DMA was significantly increased in the presence of betaCD (33-fold) and was classified as A(L)-type, indicating the 1:1 stoichiometric inclusion complexes. Solid complexes prepared by different methods (kneading, coevaporation, freeze drying) and physical mixture were characterized by differential scanning calorimetry, thermogravimetry, infrared absorption and optical microscopy. Preparation methods influenced the physicochemical properties of the products. The dissolution profiles of solid complexes were determined and compared with those DMA alone and their physical mixture, in three different mediums: simulated gastric fluid (pH 1.2), simulated intestinal fluid (pH 7.4) and distilled water. The dissolution studies showed that in all mediums DMA presented an incomplete dissolution even in four hours. In contrast, the complexes formed presented a higher dissolution rate in simulated gastric fluid (SGF pH 1.2), which indicate that these have different ionization characteristics. According to the results, the freeze-dried and kneaded products exhibited higher dissolution rates than the drug alone, in all the mediums.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446497      PMCID: PMC2976901          DOI: 10.1208/s12249-008-9042-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  14 in total

1.  Study of the inclusion complex of atenolol with beta-cyclodextrins.

Authors:  R Ficarra; P Ficarra; M R Di Bella; D Raneri; S Tommasini; M L Calabrò; A Villari; S Coppolino
Journal:  J Pharm Biomed Anal       Date:  2000-08-01       Impact factor: 3.935

2.  Cyclodextrin Drug Carrier Systems.

Authors:  Kaneto Uekama; Fumitoshi Hirayama; Tetsumi Irie
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

Review 3.  Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.

Authors:  D C Bibby; N M Davies; I G Tucker
Journal:  Int J Pharm       Date:  2000-03-20       Impact factor: 5.875

4.  Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.

Authors:  G Zingone; F Rubessa
Journal:  Int J Pharm       Date:  2004-12-28       Impact factor: 5.875

5.  A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose.

Authors:  Shawn A Mitchell; Thomas D Reynolds; Tina P Dasbach
Journal:  Int J Pharm       Date:  2003-01-02       Impact factor: 5.875

6.  Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.

Authors:  Longxiao Liu; Suyan Zhu
Journal:  J Pharm Biomed Anal       Date:  2005-08-10       Impact factor: 3.935

7.  Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.

Authors:  Li-Ping Ruan; Bo-Yang Yu; Guang-Miao Fu; Dan-Ni Zhu
Journal:  J Pharm Biomed Anal       Date:  2005-03-02       Impact factor: 3.935

8.  Study on the inclusion complex between beta-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application.

Authors:  Jamshid L Manzoori; Hossein Abdolmohammad-Zadeh; Mohammad Amjadi
Journal:  Farmaco       Date:  2005 Jun-Jul

9.  Cyclodextrin complexes of valdecoxib: properties and anti-inflammatory activity in rat.

Authors:  Kale Rajendrakumar; Saraf Madhusudan; Tayade Pralhad
Journal:  Eur J Pharm Biopharm       Date:  2005-05       Impact factor: 5.571

10.  Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.

Authors:  Swati Rawat; Sanjay K Jain
Journal:  Eur J Pharm Biopharm       Date:  2004-03       Impact factor: 5.571

View more
  10 in total

Review 1.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

2.  Enhancement of Simvastatin ex vivo Permeation from Mucoadhesive Buccal Films Loaded with Dual Drug Release Carriers.

Authors:  Tarek A Ahmed; Alaa O Bawazir; Waleed S Alharbi; Martin K Safo
Journal:  Int J Nanomedicine       Date:  2020-06-09

3.  Preparation, Physicochemical Characterization and I n - vitro Dissolution Studies of Diosmin-cyclodextrin Inclusion Complexes.

Authors:  Fengwei Ai; Yingli Ma; Jiayu Wang; Yanfeng Li
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

4.  Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-O-(2-Hydroxypropyl)-β-Cyclodextrin: A Joint Experimental and Theoretical Study.

Authors:  Dongxu Han; Zhongbao Han; Liyan Liu; Ying Wang; Shigang Xin; Hongbo Zhang; Zhan Yu
Journal:  Int J Mol Sci       Date:  2020-01-24       Impact factor: 5.923

5.  Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies.

Authors:  Laura Sbârcea; Ionuț-Mihai Tănase; Adriana Ledeți; Denisa Cîrcioban; Gabriela Vlase; Paul Barvinschi; Marinela Miclău; Renata-Maria Văruţ; Cristina Trandafirescu; Ionuț Ledeți
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

6.  Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.

Authors:  Tayel A Al Hujran; Mousa K Magharbeh; Almeqdad Y Habashneh; Rasha S Al-Dmour; Ashraf Aboelela; Hesham M Tawfeek
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

7.  Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.

Authors:  Suzan M Mansour; Rehab N Shamma; Kawkab A Ahmed; Nirmeen A Sabry; Gamal Esmat; Azza A Mahmoud; Amr Maged
Journal:  Int Immunopharmacol       Date:  2021-07-23       Impact factor: 4.932

8.  Synthesis of Polyamidoamine Dendrimer for Encapsulating Tetramethylscutellarein for Potential Bioactivity Enhancement.

Authors:  Daniel M Shadrack; Egid B Mubofu; Stephen S Nyandoro
Journal:  Int J Mol Sci       Date:  2015-11-04       Impact factor: 5.923

9.  Development and Optimization of Dispersible Tablet of Bacopa monnieri with Improved Functionality for Memory Enhancement.

Authors:  Vaishali Tejas Thakkar; Amol Deshmukh; Lal Hingorani; Payal Juneja; Lalji Baldaniya; Asha Patel; Tosha Pandya; Mukesh Gohel
Journal:  J Pharm Bioallied Sci       Date:  2017 Jul-Sep

10.  Studying the Complex Formation of Sulfonatocalix[4]naphthalene and Meloxicam towards Enhancing Its Solubility and Dissolution Performance.

Authors:  Tayel A Al Hujran; Mousa K Magharbeh; Samer Al-Gharabli; Rula R Haddadin; Manal N Al Soub; Hesham M Tawfeek
Journal:  Pharmaceutics       Date:  2021-06-30       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.